Trial intelligence / Profile preview

Single-dose versus multiple-dose ceftriaxone prophylaxis for elective caesarean section

PACTR202504647611828Completed

Sponsor
Aishat Otuyo
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ceftriaxone in surgical site infection (SSI) and endometritis (2 arms), sponsored by Aishat Otuyo. Primary endpoints: Surgical site infection and Endometritis. Started Aug 2024; status: completed.

02

Drugs

ceftriaxone
03

Conditions

surgical site infection (SSI)endometritis

Beyond the preview

Go deeper on PACTR202504647611828.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202504647611828.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call